Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» tebentafusp
tebentafusp
Immunocore is the latest to nab a private placement, securing $140M to pursue more TCR R&D
Endpoints
Mon, 07/18/22 - 07:13 pm
Immunocore
R&D
PIPE financing
Medigene
tebentafusp
Immunocore gets FDA breakthrough nod for eye melanoma drug ahead of planned Q3 filing
Fierce Biotech
Fri, 02/19/21 - 10:28 am
Immunocore
FDA
uveal melanoma
breakthrough therapy
tebentafusp
Hot on the heels of a positive PhIII, Immunocore hauls in $175M as it hunts its first TCR OK
Endpoints
Mon, 01/11/21 - 10:38 am
Immunocore
clinical trials
tebentafusp
uveal melanoma